Evidence map›Paper›PMID 28577362›Full record

Trial reportBMC ophthalmology2017

Serum uric acid concentration is associated with hypertensive retinopathy in hypertensive chinese adults.

Xuling Chen, Ying Meng, Jun Li, Hiacheng She, Liang Zhao, Jing Zhang, Yuan Peng, Kun Shang, Yadi Zhang, Xiaopeng Gu and 11 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus.International journal of diabetes in developing countries · 2022
    Review
  7. Review
  8. Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Xuling ChenDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Ying MengDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Jun LiDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Hiacheng SheDepartment of Tongren Hospital, Beijing, 100005, China.
Liang ZhaoDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Jing ZhangDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Yuan PengDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Kun ShangDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Yadi ZhangDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Xiaopeng GuDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Wenbin YangDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China.
Yan ZhangDepartment of Cardiology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Jianping LiDepartment of Cardiology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Xianhui QinNational Clinical Research Study Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Binyan WangNational Clinical Research Study Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Xiping XuNational Clinical Research Study Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Fanfan HouNational Clinical Research Study Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Genfu TangSchool of Health Administration, Anhui University, Hefei, 230039, China.
Rongfeng LiaoDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China.
Yong HuoDepartment of Cardiology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. huoyong@263.net.cn.
Liu YangDepartment of Ophthalmology, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. lucy02114@163.com.
Peking University First Hospital · CNPeking University · CNNanfang Hospital · CNAnhui Medical University · CNAnhui University · CNSouthern Medical University · CNTongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis cross sectional investigation included 12,966 subjects with hypertension, a cohort of the China Stroke Primary Prevention Trial (CSPPT), a randomized, multicenter clinical trial. This study aimed to explore the correlation between serum uric acid (SUA) concentration and hypertensive retinopathy in hypertensive adults.

methodsDiagnosis of hypertensive retinopathy was determined by non-mydriatic fundus photography and classified with Keith-Wagener-Barker (KWB) system. The correlation of SUA levels with hypertensive retinopathy prevalence and severity was assessed by statistical analysis.

results9848 (75.95%) subjects were diagnosed with hypertensive retinopathy with the following retinopathy grade distribution: grade 1: 58.80%, grade 2: 14.81%, and grade 3-4: 2.34%. SUA levels were significantly associated with hypertensive retinopathy prevalence. Patients with hypertensive retinopathy had higher SUA levels than those without hypertensive retinopathy. Patients in the highest uric acid quartile had an odds ratio for hypertensive retinopathy of 1.21 compared to patients in the lowest uric acid quartile (OR = 1.21, 95% CI: 1.05-1.40, P = 0.008). When compared to the non-hyperuricemia group, those in the hyperuricemia group had an odds ratio for hypertensive retinopathy of 1.18(OR = 1.18, 95% CI: 1.05-1.33, P = 0.004). Every 1 mg/dl increase in uric acid concentration was significantly associated with a 6% higher odds of hypertensive retinopathy (OR = 1.06, 95% CI: 1.02-1.10, P = 0.002).

conclusionsThe prevalence of hypertensive retinopathy was high (75.95%) among hypertensives in our patients cohort. In addition, SUA concentration was significantly associated with hypertensive retinopathy.

Indexed as

AdultAgedAged, 80 and overBiomarkersChinaCross-Sectional StudiesDouble-Blind MethodFemaleFollow-Up StudiesHumansHypertensionHypertensive RetinopathyIncidenceMaleMiddle AgedRetinaBiomarkersUric AcidHypertensionHypertensive RetinopathyHyperuricemiaKeith-Wagener-Barker systemSerum Uric Acid Concentration

Identifiers

PMID28577362
PMCPMC5457596
OpenAlexW2620819058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.